Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
26.78
-0.34 (-1.25%)
At close: Jan 16, 2026, 4:00 PM EST
26.76
-0.02 (-0.07%)
After-hours: Jan 16, 2026, 7:10 PM EST
Caris Life Sciences Employees
Caris Life Sciences had 1,769 employees as of December 31, 2024. The number of employees increased by 1 or 0.06% compared to the previous year.
Employees
1,769
Change (1Y)
1
Growth (1Y)
0.06%
Revenue / Employee
$366,909
Profits / Employee
-$385,449
Market Cap
7.56B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,769 | 1 | 0.06% |
| Dec 31, 2023 | 1,768 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CAI News
- 8 months ago - Caris Life Sciences Files Registration Statement for Proposed Initial Public Offering - PRNewswire
- 8 months ago - Caris Life Sciences discloses rise in revenue in US IPO filing - Reuters
- 8 months ago - Oncology precision medicine platform Caris Life Sciences files for an estimated $300 million IPO - Renaissance Capital
- 8 months ago - Caris Life Sciences IPO Registration Document (S-1) - SEC